Skippack Medical Lab, LLC

Skippack Medical Lab, LLC was paid $760K by Medicaid between Jun 2020 and May 2024, across 24 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 74% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Pennsylvania

Rank by total paid#27 of 95

Median peer was paid$153K

This provider vs. median5.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	3,957	$140K
2021	11,012	$365K
2022	6,566	$238K
2023	2,821	$3K
2024incomplete	431	$14K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	74%	8,678	7,782	$561K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	14%	8,667	7,770	$110K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	6.8%	2,533	2,192	$52K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.8%	281	150	$14K
86328		1.4%	227	216	$11K
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	<1%	2,821	2,809	$3K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	186	160	$2K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	186	160	$2K
87581		<1%	186	160	$1K
87486		<1%	186	160	$1K
87799		<1%	127	102	$986.16
87640		<1%	186	160	$800.60

12 more codes

87541		<1%	126	$469.45
87634		<1%	60	$400.34
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	187	$389.00
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	18	$38.00
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	18	$38.00
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	18	$28.07
86803		<1%	16	$19.00
80061	Lipid panel	<1%	16	$15.00
80053	Comprehensive metabolic panel	<1%	16	$10.50
83036	Hemoglobin; glycosylated (A1C)	<1%	16	$6.60
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	16	$5.00
86592		<1%	16	$1.50

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVAHORA, AABEDA (OWNER)